This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Technical University of Darmstadt, Trinity College Dublin. Active years: 2001-2013.
Company Filing History:
6 out of 1,333 
1 out of 37 
1 out of 141 
Years Active: 2001-2013
Title: Eckhard Mandelkow: Innovator in Neurodegenerative Disease Research
Introduction
Eckhard Mandelkow is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patented inventions. With a total of 6 patents, Mandelkow's work focuses on developing therapeutic solutions for conditions such as Alzheimer's disease.
Latest Patents
Mandelkow's latest patents include groundbreaking inventions aimed at treating neurodegenerative diseases. One notable patent is for thiazolhydrazides, which describes compounds featuring a thiazolhydrazide scaffold. These compounds, along with their pharmaceutically acceptable salts, can be utilized for the prophylaxis and treatment of neurodegenerative diseases. Another significant patent involves a novel neuronal protein kinase (NPK-110), which phosphorylates tau proteins and other microtubule-associated proteins. This invention has implications for the treatment of Alzheimer's disease and cancer, as it includes pharmaceutical compositions and diagnostic methods for detecting these conditions.
Career Highlights
Throughout his career, Mandelkow has worked with esteemed institutions such as the Max Planck Society for the Advancement of Science and Technische Universität Darmstadt. His research has been pivotal in advancing our understanding of neurodegenerative diseases and developing potential treatments.
Collaborations
Mandelkow has collaborated with notable colleagues, including Jacek Biernat and Gerard Drewes. These partnerships have further enriched his research and contributed to the success of his inventions.
Conclusion
Eckhard Mandelkow's innovative work in the field of neurodegenerative diseases has led to significant advancements in treatment options. His contributions through patents and collaborations continue to impact the scientific community and improve the lives of those affected by these conditions.